1. Home
  2. LSCC vs CORT Comparison

LSCC vs CORT Comparison

Compare LSCC & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lattice Semiconductor Corporation

LSCC

Lattice Semiconductor Corporation

HOLD

Current Price

$95.86

Market Cap

17.2B

Sector

Technology

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$86.90

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSCC
CORT
Founded
1983
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.2B
9.7B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
LSCC
CORT
Price
$95.86
$86.90
Analyst Decision
Strong Buy
Buy
Analyst Count
14
5
Target Price
★ $164.21
$141.00
AVG Volume (30 Days)
★ 1.7M
649.2K
Earning Date
11-02-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.29
0.09
Revenue
$385,961,000.00
★ $761,407,000.00
Revenue This Year
$75.77
$50.53
Revenue Next Year
$45.13
$48.90
P/E Ratio
★ $331.90
$1,194.51
Revenue Growth
N/A
★ 12.79
52 Week Low
$60.50
$28.66
52 Week High
$157.01
$126.38

Technical Indicators

Market Signals
Indicator
LSCC
CORT
Relative Strength Index (RSI) 28.90 24.86
Support Level $92.88 $77.38
Resistance Level $101.49 $122.93
Average True Range (ATR) 5.05 6.12
MACD -3.03 -2.51
Stochastic Oscillator 4.11 7.50

Price Performance

Historical Comparison
LSCC
CORT

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: